InBios International

InBios International is a biotechnology company located in Seattle, Washington, specializing in the design, development, and manufacture of immunodiagnostic products for infectious diseases. Founded in 1996, the company offers over 25 diagnostic products and a wide range of life science reagents, focusing on providing accurate and cost-effective solutions for the global public health market. The company provides a variety of diagnostic tests, including rapid tests and ELISA-based assays for diseases such as Zika virus, West Nile virus, chikungunya, COVID-19, and Lyme disease. InBios also offers custom assay development and analyte-specific reagents, with the ability to scale production quickly in response to public health needs. Their commitment to innovation is evident through partnerships with academic and government entities, enhancing their research and development efforts. InBios serves a diverse customer base, including public health organizations, research institutions, and private companies. Their products are recognized for their reliability and accessibility, playing a vital role in addressing infectious diseases that impact millions worldwide. The company adheres to rigorous quality standards, with many products FDA cleared and manufactured under Good Manufacturing Practices.

• Employees 240
• Founded 1996
• Annual Revenue $17655000